Blood glucose variability in early-onset adrenocorticotropic hormone deficiency induced by immune checkpoint inhibitor therapy with continuous blood glucose monitoring: a case report [0.03%]
免疫检查点抑制剂治疗早期发生的促肾上腺皮质激素缺乏所致血糖波动一例报告
Yuta Nanao,Gentaro Egusa,Ryuta Baba et al.
Yuta Nanao et al.
Early diagnosis and treatment of immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICIs) are essential because they directly impact patient quality of life. This report describes the case of an 85-year-old ...
Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes [0.03%]
司美格鲁肽口服制剂因不良反应而停药：针对日本2型糖尿病患者的数据库研究
Mizuki Ishiguro,Rimei Nishimura
Mizuki Ishiguro
The global prevalence of diabetes continues to rise, necessitating advancements in treatment, such as glucagon-like peptide-1 receptor agonists. While oral semaglutide has demonstrated comparable efficacy to injectable formulations, gastroi...
Effects of finerenone with and without angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on albuminuria in patients with diabetes and chronic kidney disease [0.03%]
芬戈利蒙特单用及与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂联用对糖尿病肾病患者白蛋白尿的影响
Saori Inoue,Takashi Kamiya,Reiichiro Fujita et al.
Saori Inoue et al.
Aims: Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) are the foundation of renoprotective therapy in chronic kidney disease (CKD). However, some patients cannot tolerate these ag...
Concurrent diabetes and heart failure: revisiting epidemiological and clinicopathological interplay [0.03%]
糖尿病和心力衰竭的并发：重新审视流行病学和临床病理学的相互作用
Jayagopal Pathiyil Balagopalan,Sandeep Bansal,Arpandev Bhattacharyya et al.
Jayagopal Pathiyil Balagopalan et al.
The global prevalence of diabetes mellitus (DM) and heart failure (HF) is rapidly increasing. Hyperglycemia, insulin resistance and hyperglycemia-induced oxidative stress in people with DM are the key etiological factors of HF. The factors ...
Qian-Qian Lu,Zhao Zheng,Peng Wang et al.
Qian-Qian Lu et al.
Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by hyperglycemia, insulin resistance, and β-cell dysfunction. It is a complex disease involving the interaction of genetic, environmental, and lifestyle factors. Three-dim...
Insulin edema in slowly progressive type 1 diabetes: improvement following adjustment of insulin therapy [0.03%]
1型糖尿病的胰岛素水肿：调整胰岛素治疗后的改善
Emi Okamura,Norio Harada,Kana Okuno et al.
Emi Okamura et al.
Insulin edema is an uncommon complication that typically arises soon after initiating insulin therapy, most often in individuals with newly diagnosed diabetes or poorly controlled hyperglycemia. An old report from a single hospital in Afric...
A case-control study on the prevalence of depression and its biomarkers in Type 2 diabetes mellitus patients [0.03%]
2型糖尿病患者抑郁患病率及其生物标志物的病例对照研究
Haya Majid,Sajad Ul Islam,Sunil Kohli et al.
Haya Majid et al.
Purpose: Type 2 diabetes mellitus (T2DM) is a common metabolic disease that impacts patients' physical and mental well-being and is frequently linked to concomitant depression. This study aimed to explore prevalence the c...
Yang Yanru,Cui Jia,Yu Yan
Yang Yanru
Background: Diabetic nephropathy (DN) represents the most common cause of end-stage renal disease (ESRD) worldwide, affecting 20-40% of diabetic patients. Current therapeutic strategies remain insufficient to halt disease...
Association of serum levels of carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) with diabetes mellitus (DM): a systematic review and meta-analysis [0.03%]
碳氢化合物抗原19-9（CA19-9）和癌胚抗原（CEA）的血清水平与糖尿病相关性的系统评价和meta分析
Ali Nawaz,Shayan Asmat,Rana Ijaz et al.
Ali Nawaz et al.
Background: Type 2 diabetes mellitus (T2DM) affects 537 million people worldwide, with its prevalence and complications continuing to rise despite advancements in treatment. Identifying novel biomarkers associated with gl...
Relationship between changes in uric acid levels and renal function during 12 months of treatment with luseogliflozin [0.03%]
卢塞列净治疗12个月期间尿酸水平和肾功能变化之间的关系
Takuma Izutsu,Hiroyuki Ito,Suzuko Matsumoto et al.
Takuma Izutsu et al.
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors can effectively improve blood glucose levels in patients with type 2 diabetes, reduce the risk of cardiovascular disease and heart failure, and prevent chronic...